Dosekun A - Search Results

1

Impact of dialysis modality on survival of new ESRD patients with congestive heart failure in the United States.

Stack AG, Molony DA, Rahman NS, Dosekun A, Murthy B. Stack AG, et al. Among authors: dosekun a. Kidney Int. 2003 Sep;64(3):1071-9. doi: 10.1046/j.1523-1755.2003.00165.x. Kidney Int. 2003. PMID: 12911559 Free article.

2

Successful treatment of mucormycosis peritonitis with liposomal amphotericin B in a patient on long-term peritoneal dialysis.

Serna JH, Wanger A, Dosekun AK. Serna JH, et al. Among authors: dosekun ak. Am J Kidney Dis. 2003 Sep;42(3):E14-7. doi: 10.1016/s0272-6386(03)00797-2. Am J Kidney Dis. 2003. PMID: 12955706

3

Evaluation of treatment in lupus nephritis: effects of prednisone.

Pollak VE, Dosekun AK. Pollak VE, et al. Among authors: dosekun ak. Am J Kidney Dis. 1982 Jul;2(1 Suppl 1):170-7. Am J Kidney Dis. 1982. PMID: 7102665

4

Deficiency of a plasma factor stimulating vascular prostacyclin generation in patients with lupus nephritis and glomerular thrombi and its correction by ancrod: in-vivo and in-vitro observations.

Kant KS, Dosekun AK, Chandran KG, Glas-Greenwalt P, Weiss MA, Pollak VE. Kant KS, et al. Among authors: dosekun ak. Thromb Res. 1982 Sep 15;27(6):651-8. doi: 10.1016/0049-3848(82)90003-2. Thromb Res. 1982. PMID: 6758185

5

Ancrod in systemic lupus erythematosus with thrombosis. Clinical and fibrinolysis effects.

Dosekun AK, Pollak VE, Glas-Greenwalt P, Kant KS, Penovich P, Lebron-Berges A, Weiss MA, Levinson JE. Dosekun AK, et al. Arch Intern Med. 1984 Jan;144(1):37-42. Arch Intern Med. 1984. PMID: 6229228

6

Successful treatment by defibrination with ancrod in a patient with hyperacute renal allograft failure and a deficiency of plasma prostacyclin stimulating factor.

Dosekun AK, First MR, Chandran PK, Kant KS, Glas-Greenwalt P, Weiss MA, Alexander JW, Pollak VE. Dosekun AK, et al. Clin Nephrol. 1982 Aug;18(2):101-5. Clin Nephrol. 1982. PMID: 6754189

7

Ancrod: normalization of fibrinolytic enzyme abnormalities in patients with systemic lupus erythematosus and lupus nephritis.

Glas-Greenwalt P, Kant KS, Dosekun A, Frazier J, Allen C, Pollak VE. Glas-Greenwalt P, et al. Among authors: dosekun a. J Lab Clin Med. 1985 Jan;105(1):99-107. J Lab Clin Med. 1985. PMID: 3871465

8

Lupus nephritis with thrombosis and abnormal fibrinolysis: effect of ancrod.

Kant KS, Pollak VE, Dosekun A, Glas-Greenwalt P, Weiss MA, Glueck HI. Kant KS, et al. Among authors: dosekun a. J Lab Clin Med. 1985 Jan;105(1):77-88. J Lab Clin Med. 1985. PMID: 3968467

9

Carbon dioxide-angiography for patients with peripheral arterial disease at risk of contrast-induced nephropathy.

Gupta A, Dosekun AK, Kumar V. Gupta A, et al. Among authors: dosekun ak. World J Cardiol. 2020 Feb 26;12(2):76-90. doi: 10.4330/wjc.v12.i2.76. World J Cardiol. 2020. PMID: 32184976 Free PMC article. Review.

10

Advances in genetic detection of kidney disease.

Dosekun AK, Foringer JR, Kone BC. Dosekun AK, et al. Saudi J Kidney Dis Transpl. 2003 Jul-Sep;14(3):259-75. Saudi J Kidney Dis Transpl. 2003. PMID: 17657098 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results